Free_articles - Articles - Page 3

CLINICAL UPDATE

Perioperative Pain Management in Opioid Use Disorder

March 19, 2021

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Previously, clinicians commonly stopped opioid agonists (methadone and buprenorphine) to simplify pain control during and after surgery. New guidance from the American Society of Addiction Medicine now suggests otherwise.

CLINICAL UPDATE

Prescribing to Children of Divorce

March 12, 2021

Anthony Charuvastra, MD.

Anthony Charuvastra, MD. Adjunct Assistant Professor, NYU Langone Medical Center Department of Child and Adolescent Psychiatry. Dr. Charuvastra has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What is the best approach to effective clinical care with families that are separated or divorced? This article covers the complexities, the legalities, and an expectation of collaboration that can help us to help children to receive good mental health care despite the inevitable differences between parents in these situations.

EXPERT Q&A

Managing Video Gaming in Children and Teens

October 30, 2020

Joseph B. Dilley, PhD

Joseph B. Dilley, PhD
Psychologist in Pasadena, CA; author of The Game Is Playing Your Kid: How to Unplug and Reconnect in the Digital Age (Minneapolis: Bascom Hill; 2015). Dr. Dilley has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

So many families struggle with videogaming addiction and other overuse of electronics, maybe more so in the current pandemic. Joe Dilley teaches us how to address this perennial problem, offering a simple way to remember how families can set up their limits in a way that pitches the child toward better self-control.

The “Z-Drugs”: Safety Issues and Misuse Potential

June 10, 2020

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Once heralded for their relative safety compared to benzodiazepines, the “Z-drugs” are now known to be one of the most common causes of adverse drug events. Here we review the risks of Z-drugs and highlight updated dosing recommendations for zolpidem.

A Potentially Lethal Side Effect You Probably Never Heard Of

May 7, 2020

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA recently raised alerts about a potentially fatal side effect on clozapine that’s causing more fatalities than neutropenia. It’s constipation, and the problem extends to a few other psychotropics as well. In this article, a three step, evidence-based algorithm for managing it.

Reducing the Stigma of Addiction Through Language and Terminology

March 30, 2020

Specific terms and phrases, when used among health professionals, can lead to more punitive treatment plans and increased stigma perceived by patients. Learn the evidence base behind recent recommendations among medical societies, journals, and periodicals to use more person-centered language.

Oxcarbazepine: Close, but no Cigar

March 9, 2020

Oxcarbazepine is thought of as a kinder, gentler cousin of carbamazepine, but it brings new safety issues of its own and does not fully escape the drug interactions that hinder carbamazepine. We pull on the published and unpublished trials to figure out where this anticonvulsant stands in bipolar disorder.

Harm Reduction Strategies—A Primer

February 11, 2020

To minimize harm and optimize safety among people who use drugs, particularly injections drugs, learn the nuts and bolts of naloxone distribution, syringe exchange, pre-exposure prophylaxis (PrEP) for HIV prevention, and fentanyl testing.

Getting Uncomfortable with Esketamine

January 13, 2020

Nolan Williams, MD

Nolan Williams, MD

Director of the Brain Stimulation Lab and Interventional Psychiatry Clinical Research Program; Assistant Professor of Psychiatry at Stanford University, CA. Dr. Williams has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA approval of esketamine (Spravalto) left some unanswered questions, including suicide, addiction, withdrawal, neurotoxicity, and bladder inflammation. Nolan Williams addresses those risks and looks at where esketamine fits among other options like TMS and ECT. Dr. Williams directs the Interventional Psychiatry Clinical Research Program and Brain Stimulation Lab at Stanford University.

Using Mental Health Apps

October 3, 2019

John Torous, MD, MBI

John Torous, MD, MBI

Director of the digital psychiatry division, Department of Psychiatry at Beth Israel Deaconess Medical Center, Boston, MA Dr. Torous has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prescription apps have arrived, but Dr. Torous reminds us that the key ingredient in a mental health app is something we’ve been using all along: the therapeutic relationship.